Cresco Labs Inc. (CRLBF) reported a quarterly loss of $0.02 per share for the period ended December 2025, matching the Zacks Consensus Estimate but slightly worse than the $0.01 loss in the same quarter last year. The company achieved revenues of $161.55 million, exceeding expectations by 0.26%, despite a decline from $175.91 million a year ago. Over the last four quarters, Cresco has met or surpassed revenue estimates three times, but has surpassed EPS estimates only once.
YTD, Cresco Labs shares have decreased by approximately 20.7%, contrasting with a 0.4% gain in the S&P 500. Looking ahead, the current consensus EPS estimate for the upcoming quarter stands at -$0.03 with revenues projected at $162 million, and for the fiscal year at -$0.09 on revenue of $670.41 million. The Zacks Rank for Cresco is currently #4 (Sell), indicating expected underperformance in the near term.
